Skip to main content
RAPS Euro Convergence 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed Event
Ticketed Event
Sponsored Presentation
Sponsored Presentation
Learning Level: Foundational
Learning Level: Foundational
New Exhibitor
New Exhibitor
Networking Event
Networking Event
Enterprise Network Member
Enterprise Network Member
Learning Level: Expert
Learning Level: Expert
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Intermediate
Learning Level: Intermediate
Back

Rebecca Lumsden, PhD

Head of Regulatory Science & Policy EU/AMEE
Sanofi

Rebecca joined Sanofi in 2022 to lead their regulatory science and policy efforts in Europe, Africa and the Middle East and coordinate specific global projects with a goal of fostering new approaches for early access of medicines for the benefit of patients. Focus areas include expedited regulatory pathways, regulatory convergence, digital transformation and includes adapting regulatory frameworks to new science and in support of innovative technologies. She is actively involved within EFPIA including Co-Chair of the European Regulatory Affairs and Operations (ERAO) group, is a member of a CIRS topic group and co-leads a workstream in the IDERHA (Integration of Heterogeneous Data and Evidence towards Regulatory and HTA Acceptance) IHI consortia.

Before joining Sanofi, Rebecca was a Director in the Global Regulatory Policy & Intelligence team at Pfizer and also held the role of Co-Chair of the FIFARMA’s Regulatory and Biologics Working Group (2020-2022). Her career has included 8 years at the UK Trade Association (ABPI) working on numerous policy issues relevant to the biopharmaceutical industry including science and innovation policy. She was a post-doctoral scientist prior to her career in policy, with a PhD from Fitzwilliam College, University of Cambridge (UK) in cell signalling.

Disclosure information not submitted.

Presentation(s):